These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19542713)

  • 1. [Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].
    Fujita Y; Nishio K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):923-6. PubMed ID: 19542713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
    Pentheroudakis G; Golfinopoulos V; Pavlidis N
    Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
    Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
    J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
    Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
    Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of unknown primary cancer.
    Bender RA; Erlander MG
    Semin Oncol; 2009 Feb; 36(1):38-43. PubMed ID: 19179186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hunting the primary: novel strategies for defining the origin of tumours.
    Dennis JL; Oien KA
    J Pathol; 2005 Jan; 205(2):236-47. PubMed ID: 15641019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers.
    Thukral SK; Nordone PJ; Hu R; Sullivan L; Galambos E; Fitzpatrick VD; Healy L; Bass MB; Cosenza ME; Afshari CA
    Toxicol Pathol; 2005; 33(3):343-55. PubMed ID: 15805072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiclass cancer classification by support vector machines with class-wise optimized genes and probability estimates.
    Anand A; Suganthan PN
    J Theor Biol; 2009 Aug; 259(3):533-40. PubMed ID: 19406131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
    van Laar RK; Ma XJ; de Jong D; Wehkamp D; Floore AN; Warmoes MO; Simon I; Wang W; Erlander M; van't Veer LJ; Glas AM
    Int J Cancer; 2009 Sep; 125(6):1390-7. PubMed ID: 19536816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test.
    Monzon FA; Dumur CI
    Expert Rev Mol Diagn; 2010 Jan; 10(1):17-25. PubMed ID: 20014919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cancer of unknown primary, today and future].
    Shibata H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
    Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
    Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How large a training set is needed to develop a classifier for microarray data?
    Dobbin KK; Zhao Y; Simon RM
    Clin Cancer Res; 2008 Jan; 14(1):108-14. PubMed ID: 18172259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient identification of miRNAs for classification of tumor origin.
    Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
    J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.